Skip to Content

Evotec SE EVOTF

Morningstar Rating
$8.98 −0.87 (8.83%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EVOTF is trading at a 638% premium.
Price
$9.82
Fair Value
$92.61
Uncertainty
Very High
1-Star Price
$23.43
5-Star Price
$71.35
Economic Moat
Xtrk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EVOTF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$9.85
Day Range
$8.988.98
52-Week Range
$8.9825.48
Bid/Ask
$8.60 / $9.37
Market Cap
$1.59 Bil
Volume/Avg
182 / 1,098

Key Statistics

Price/Earnings (Normalized)
18.13
Price/Sales
1.88
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
5,055

Competitors

Valuation

Metric
EVOTF
CTLT
CRL
Price/Earnings (Normalized)
18.1397.4020.66
Price/Book Value
1.332.782.96
Price/Sales
1.882.442.63
Price/Cash Flow
43.7941.3314.15
Price/Earnings
EVOTF
CTLT
CRL

Financial Strength

Metric
EVOTF
CTLT
CRL
Quick Ratio
1.931.561.00
Current Ratio
2.162.511.52
Interest Coverage
−6.83−4.075.21
Quick Ratio
EVOTF
CTLT
CRL

Profitability

Metric
EVOTF
CTLT
CRL
Return on Assets (Normalized)
−4.21%−3.09%6.50%
Return on Equity (Normalized)
−8.08%−7.79%15.17%
Return on Invested Capital (Normalized)
−5.57%−0.96%9.55%
Return on Assets
EVOTF
CTLT
CRL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
NqpffhwzBkngxch$80.3 Bil
Zoetis Inc Class A
ZTS
BhfbpcfmyMnmd$78.2 Bil
Haleon PLC ADR
HLN
XcdnydtzXjvw$38.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
SbxyqbldHkz$12.1 Bil
Viatris Inc
VTRS
DjcwxppzhMyky$12.1 Bil
Catalent Inc
CTLT
YkhxddqhSxlcft$10.0 Bil
Perrigo Co PLC
PRGO
RhbtzjvhFpvn$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
YxmdwfmHsqfdcs$3.2 Bil
Curaleaf Holdings Inc
CURLF
YrvgqfmrHxnvt$3.0 Bil
Green Thumb Industries Inc
GTBIF
RpynlqvjdFtsp$2.7 Bil

Sponsor Center